Managed $3.5 M territory for sales of inhaled anesthetics to large-scale hospital systems, PSA 4000 level of consciousness monitor, and transderm scopolamine. Partnered with IDN Baxter managers to formulate and refine account strategies that grow and protect Inhaled Anesthetic base business. Accountable for Results & GP in University of Texas MD Anderson Cancer Center, The Methodist Hospital System, Harris Country Hospital District, Baylor College of Medicine, Memorial Hermann System, UTMB… Show more Managed $3.5 M territory for sales of inhaled anesthetics to large-scale hospital systems, PSA 4000 level of consciousness monitor, and transderm scopolamine. Partnered with IDN Baxter managers to formulate and refine account strategies that grow and protect Inhaled Anesthetic base business. Accountable for Results & GP in University of Texas MD Anderson Cancer Center, The Methodist Hospital System, Harris Country Hospital District, Baylor College of Medicine, Memorial Hermann System, UTMB Hospital System, HCA Gulf Coast Hospital System, Seton Hospital System, St David's Hospital System, St Luke's CHI System.•Built and established fast growth territory across Beaumont Hospital Systems in Houston, Texas, cultivating strong working relationships with directors in supply chain, pharmacists, anesthesiologists, nurse anesthetists, and perioperative services.•Increased market share of primary product Suprane from 34% to 91% and recognized for #1 volume Suprane account nationally by working closely with key stakeholders at MD Anderson Cancer Center, identifying clinical needs, and aligning product benefits with clearly defined clinical metrics. •Retained Suprane against corporate initiative for elimination at Christus St. Elizabeth hospital by utilizing high-influence clinicians collaborating with hospital executives, pharmacy, realizing value proposition of $175K annual sales. Selected Accomplishments• Recognized with Distinguished Sales Club for top 5% of sales force• Received Presidents Club for 3 different years for achieving top 15% of sales force• Grew yearly unit volume from 5500 units to 34,000+ units Transderm Scopolamine (2004-2015)• Increased yearly Sevoflurane unit volume from 1700 units to 20,600+ units (2007-2015) • #1 Teaching Center Representative Hardware Sales (268%) & Disposables (212%) 2004• Developed high influence KOL’s @ MD Anderson Cancer Center that drove national sales. Show less

I Developed and managed $3M territory. Gained Resident adoption of Suprane as preferred agent in appropriate cases by alignment of product benefits with their needs and by proctoring Anesthesia Residents to teach current appropriate anesthesia technique. with the product. Facilitated educational training. •Developed strategy based on understanding of clinic metric objectives and conducted OR trials for PSA 4000 Consciousness monitor, resulting in closure of 25 units with MD Anderson… Show more I Developed and managed $3M territory. Gained Resident adoption of Suprane as preferred agent in appropriate cases by alignment of product benefits with their needs and by proctoring Anesthesia Residents to teach current appropriate anesthesia technique. with the product. Facilitated educational training. •Developed strategy based on understanding of clinic metric objectives and conducted OR trials for PSA 4000 Consciousness monitor, resulting in closure of 25 units with MD Anderson Cancer Center (#1/15 representatives) 174% plan.•Displaced imbedded competitor and increased Sevoflurane revenue $1.7M, promoting, negotiating, and closing 5-year agreement with Methodist Hospital System.•Gained approval for Suprane by developing influential relationships with KOLs at Memorial Hermann Hospital, implementing consultative sales strategy, and proctoring OR cases with anesthesia residents, driving $69K yearly incremental sales Show less

Sold critical care drug for CHF with call points, including CCUs, MICUs, transplant units, cardiology, CV anesthesiologists.

I successfully launched and grew market share for Imitrex; (neurologists) and Zofran for Nausea/Vomit (oncologists) to exceed sales objectives.